P.0004 IMPLANTS
Device Facts
| Record ID | K062129 |
|---|---|
| Device Name | P.0004 IMPLANTS |
| Applicant | Institut Straumann AG |
| Product Code | DZE · Dental |
| Decision Date | Oct 20, 2006 |
| Decision | SESE |
| Submission Type | Special |
| Regulation | 21 CFR 872.3640 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Indications for Use
The P.004 Implants are intended for immediate, delayed or conventional placement in the maxilla and/or mandibular arches to support crowns bridges or overdentures in edentulous or partially edentulous patients. They are intended for immediate function on single-tooth and/or multiple tooth applications when good primary stability is achieved and with appropriate occlusal loading, to restore chewing function. Multiple tooth applications may be rigidly splinted. In the case of edentulous patients, 4 or more implants must be used. Abutments are intended to be placed into dental implants to provide support for prosthetic reconstructions such as crowns or bridges. Meso abutments are indicated for cemented restorations particularly in esthetic areas of the mouth. The abutment can be used in single tooth replacements and multiple tooth restorations.
Device Story
P.004 Implant is a solid screw-type endosseous dental implant; used to support prosthetic restorations (crowns, bridges, overdentures). Composed of Grade 4 commercially pure titanium; features SLA (grit-blasted/acid-etched) or SLActive surface. Includes titanium Meso abutments and healing caps as accessories. Used by dental professionals in clinical settings for single or multiple tooth replacement. Implant provides structural foundation for prosthetic reconstruction; abutment connects implant to restoration. Benefits include restoration of chewing function and esthetic support in oral cavity.
Clinical Evidence
No clinical data provided; substantial equivalence based on design, material, and intended use comparisons to predicate devices.
Technological Characteristics
Material: Grade 4 commercially pure titanium. Surface: SLA (grit-blasted/acid-etched) or SLActive. Form factor: Solid screw implant with associated abutments and healing caps. Energy source: None (mechanical).
Indications for Use
Indicated for edentulous or partially edentulous patients requiring support for crowns, bridges, or overdentures in the maxilla or mandible. Supports immediate, delayed, or conventional placement and immediate function if primary stability is achieved.
Regulatory Classification
Identification
An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.
Special Controls
*Classification.* (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2) *Classification.* Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use; (ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads; (iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system; (iv) The device must be demonstrated to be biocompatible; (v) Sterility testing must demonstrate the sterility of the device; (vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment; (vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians; (viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and (ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.